Loading insider details...
Latest Form 4 (Aug 4, 2026): Grant/Award of 32,246 ETON shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 4, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 32,246 | n/a |
| Apr 4, 2023 | Iterum Therapeutics plc (ITRM) | Grant/Award | 100,000 | n/a |
| Mar 14, 2023 | Iterum Therapeutics plc (ITRM) | Grant/Award | 6,666 | n/a |
| Mar 15, 2022 | Iterum Therapeutics plc (ITRM) | Grant/Award | 100,000 | n/a |
| Jun 25, 2021 | Iterum Therapeutics plc (ITRM) | Grant/Award | 1,936,000 | n/a |
| Mar 15, 2021 | Iterum Therapeutics plc (ITRM) | Grant/Award | 200,000 | n/a |
| Jan 28, 2021 | Iterum Therapeutics plc (ITRM) | Grant/Award | 62,500 | n/a |
| Oct 3, 2020 | Iterum Therapeutics plc (ITRM) | Sale | 56,130 | $92.1K |